Market Update

Adani Ports gains as brokerages raise target on strong Q1 show

Adani Ports and the Special Economic Zone opened higher on August 9 as brokers confidence in the stock, with some even increasing target price, a day after the company’s strong performance in first quarter of the current year. The company recorded an increase of 82.57% year-on-year in consolidated net profit to Rs 2,114.72 in the …

Adani Ports gains as brokerages raise target on strong Q1 show Read More »

Utkarsh Small Finance Bank share falls 1% despite strong Q1 numbers

Shares of Utkarsh Small Finance Bank fell nearly 1% to Rs 50.75 on August 9, although the bank released strong quarterly figures. Quarterly net profit increased 20.1% YoY to Rs 107.5 Rs crore, thanks to lower provisions and provisions. Net interest income – the difference between how much interest a bank earns and what it …

Utkarsh Small Finance Bank share falls 1% despite strong Q1 numbers Read More »

New Information Edge: Wealthy investors rush to outer space in pursuit of higher returns

Post-Covid has proven to be a golden age for retail investors to get into stocks. Thanks to the proliferation of fintech applications and stricter disclosure rules imposed by the Securities and Exchange Commission of India (Sebi) on businesses, most of the data and related information is now just a click or a swipe. According to …

New Information Edge: Wealthy investors rush to outer space in pursuit of higher returns Read More »

Solara Active Pharma Sciences gain on USFDA all-clear for Cuddalore unit

Shares of Aurobindo Pharma rose 2% to test a 52-week high of Rs 860.85 on Aug 7 after the company was approved for the drug by the US Food and Drug Administration (FDA). vancomycin hydrochloride injection. At 09:52, Aurobindo Pharma was trading at Rs 859.95, up Rs 18.15, or 2.16% on BSE. The Company’s wholly …

Solara Active Pharma Sciences gain on USFDA all-clear for Cuddalore unit Read More »

Aurobindo Pharma shares hit 52-week high on US FDA approval for drug to treat infection

Shares of Aurobindo Pharma rose 2% to test a 52-week high of Rs 860.85 on Aug 7 after the company was approved for the drug by the US Food and Drug Administration (FDA). vancomycin hydrochloride injection. At 09:52, Aurobindo Pharma was trading at Rs 859.95, up Rs 18.15, or 2.16% on BSE. The Company’s wholly …

Aurobindo Pharma shares hit 52-week high on US FDA approval for drug to treat infection Read More »

Reliance forecasts healthy oil demand on the back of steady economic growth

Reliance Industries Limited predicts in its fiscal 2023 annual report that oil demand is expected to remain healthy thanks to steady economic growth. The company said new supply from upcoming refining capacity in the Middle East, China and Africa will keep the market in balance. “Oil prices and commodity cracks will remain stable as global …

Reliance forecasts healthy oil demand on the back of steady economic growth Read More »